e-Drug3D

1223

MAFENIDE


INN
MAFENIDE

cas 138-39-6
CLASS

DERMATOLOGICALS
ANTIBACTERIAL
SULFONAMIDES
ANTIBIOTIC

ROUTE (list)

TOPICAL

ATC code

D06BA03

PK parameters

Tmax 2 HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET CARBONIC ANHYDRASE (SECONDARY TARGET)

PDB
5JNC (CRYSTAL STRUCTURE FOR THE COMPLEX OF HUMAN CARBONIC ANHYDRASE IV AND 4-AMINOMETHYLBENZENE SULFONAMIDE)

Ligand code = 6LH (link to the list of PDB complexes)

Download experimental 3D coordinates of 6LH with added hydrogens

DrugCentral

Dihydropteroate synthase UNIPROT P0AC13 folP

Download SDF file Benzenesulfonamide, 4-(aminomethyl)-

Formula:
C7H10N2O2S

Calculated chemical properties:

MW 186.24
NB_atoms 12
XLogP -0.21
PSA 85.058
NB_HD 4
NB_HA 4
fsp3 0.14
Lipinski(0=no;1=yes) 1

FDA
NDA 016763 (pdf not found) INN (MAFENIDE ACETATE) SULFAMYLON (RISING) APPROVAL= AP YEAR= 1969
NDA 019832 (label) INN (MAFENIDE ACETATE) SULFAMYLON (MYLAN INSTITUTIONAL) APPROVAL= AP YEAR= 1998 DISCONTINUED
NDA 201511 (pdf not found) INN (MAFENIDE ACETATE) MAFENIDE ACETATE (PH HEALTH) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 206716 (pdf not found) INN (MAFENIDE ACETATE) MAFENIDE ACETATE (NOVAST LABS) APPROVAL= AP YEAR= 2017 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL